dm+d

412556009

Articles

Safety in Lactation: Simple analgesics and combination analgesic preparations

26 October 2020Paracetamol is the simple analgesic of choice in breastfeeding mothers. Choice of an alternative will depend on level of analgesia required. Paracetamol should be adequate…
Search Articles

Medicine Compliance Aid Stability

CodiparMercury Pharmaceuticals Inc

Mercury Pharmaceuticals Inc
Codipar
Tablets coated 15/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements
11 May 2015

CodiparMercury Pharmaceuticals Inc

Mercury Pharmaceuticals Inc
Codipar
Tablets effervescent 15/500
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets - unsuitable for MCA.
11 May 2015

KapakeGalen Ltd

Galen Ltd
Kapake
Tablets 15/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements
11 May 2015

genericNon-proprietary

Non-proprietary
generic
Tablets effervescent 30/500
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets - unsuitable for MCA.
11 May 2015

genericNon-proprietary

Non-proprietary
generic
Tablets, Capsules 30/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage
11 May 2015

KapakeGalen Ltd

Galen Ltd
Kapake
Tablets 30/500
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light.
11 May 2015

SolpadolSanofi-Aventis

Sanofi-Aventis
Solpadol
Caplets, Capsules 30/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from heat
Protect from heat.
11 May 2015

SolpadolSanofi-Aventis

Sanofi-Aventis
Solpadol
Tablets effervescent 30/500
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets - unsuitable for MCA.
11 May 2015

TylexUCB Pharma Ltd

UCB Pharma Ltd
Tylex
Capsules 30/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
Protect from heat.
11 May 2015

TylexUCB Pharma Ltd

UCB Pharma Ltd
Tylex
Tablets effervescent 30/500
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets - unsuitable for MCA.
11 May 2015

genericNon-proprietary

Non-proprietary
generic
Tablets, Capsules 8/500
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements
11 May 2015

genericNon-proprietary

Non-proprietary
generic
Tablets dispersible 8/500
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets - unsuitable for MCA.
11 May 2015

Lactation Safety Information

Codeine phosphate + paracetamol

Codeine phosphate + paracetamol
No
Co-dydramol, Tramadol, Paracetamol, Ibuprofen/Diclofenac
For codeine, there are reports of apnea in breastfed infants. Report of infant death where mother was an ultrarapid metaboliser genotype which may lead to increased levels of metabolite, morphine
European and UK regulatory bodies (EMA/MHRA) have contraindicated the use of codeine
29 July 2020